Chronic Kidney Disease News

Five years after receiving a complete response letter from the agency, Lexicon Pharmaceuticals brought sotagliflozin back before an FDA advisory panel to seek an indication to treat patients with type 1 diabetes and chronic kidney disease.

SAN DIEGO — In this video exclusive from ASN Kidney Week, Healio | Nephrology News & Issues Editorial Board Member Sheila Deziel, MSN, RN, CNN, FNKF, discusses issues facing dialysis nurses.

SAN DIEGO — An educational intervention improved dialysis decision-making in veterans with advanced chronic kidney disease, according to data presented at Kidney Week.

Immunotherapy utilization for treatment of advanced kidney or bladder cancers varied by patients’ race or socioeconomic status, according to study results.

SAN DIEGO — Blood volume monitoring may lead to shorter hospital stays and fewer readmissions for adults with end-stage kidney disease and heart failure, data show.

SAN DIEGO — Oxiris membranes may offer no clinical advantage vs. standard membranes to maintain hemodynamic stability in patients with septic shock who need continuous kidney replacement therapy, data presented at ASN Kidney Week show.

SAN DIEGO — Semaglutide, a GLP-1 receptor agonist approved for treatment of obesity and type 2 diabetes, improved kidney metrics for adults with overweight and obesity without diabetes, according study data.

SAN DIEGO — Researchers reported a sudden decrease in all-cause hospitalization at the beginning of the COVID-19 pandemic, but there was an increase in all-cause mortality in patients on maintenance dialysis.

SAN DIEGO — Compared with placebo, finerenone was associated with reductions in albuminuria and decreased risk of new-onset albuminuria among adults with heart failure, according to data from the FINEARTS-HF trial.

SAN DIEGO — Earlier referral to a nephologist for patients with a hyponatremia electrolyte abnormality may be linked to shorter hospital stays and lower mortality rates, data show.